DK1068328T3 - Behandling og diagnose af stafylokokinfektioner - Google Patents
Behandling og diagnose af stafylokokinfektionerInfo
- Publication number
- DK1068328T3 DK1068328T3 DK99913444T DK99913444T DK1068328T3 DK 1068328 T3 DK1068328 T3 DK 1068328T3 DK 99913444 T DK99913444 T DK 99913444T DK 99913444 T DK99913444 T DK 99913444T DK 1068328 T3 DK1068328 T3 DK 1068328T3
- Authority
- DK
- Denmark
- Prior art keywords
- diagnosis
- treatment
- staphylococcal infections
- same
- staphylococcal
- Prior art date
Links
- 206010041925 Staphylococcal infections Diseases 0.000 title abstract 2
- 238000003745 diagnosis Methods 0.000 title abstract 2
- 241000191967 Staphylococcus aureus Species 0.000 abstract 1
- 230000003472 neutralizing effect Effects 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
- C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Oncology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9806762.2A GB9806762D0 (en) | 1998-03-31 | 1998-03-31 | Treatment and diagnosis of staphylococcal infections |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1068328T3 true DK1068328T3 (da) | 2005-12-12 |
Family
ID=10829514
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK99913444T DK1068328T3 (da) | 1998-03-31 | 1999-03-25 | Behandling og diagnose af stafylokokinfektioner |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6627730B1 (de) |
| EP (1) | EP1068328B1 (de) |
| JP (1) | JP4460156B2 (de) |
| AT (1) | ATE310088T1 (de) |
| AU (1) | AU752794B2 (de) |
| CA (1) | CA2321960A1 (de) |
| DE (1) | DE69928384T2 (de) |
| DK (1) | DK1068328T3 (de) |
| ES (1) | ES2248992T3 (de) |
| GB (1) | GB9806762D0 (de) |
| NZ (1) | NZ506196A (de) |
| WO (1) | WO1999050418A1 (de) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0014907D0 (en) * | 2000-06-20 | 2000-08-09 | Univ Sheffield | Antigenic polypeptides |
| JP4404627B2 (ja) | 2001-08-02 | 2010-01-27 | ユニヴァーシティー オヴ シェフィールド | 抗原性ポリペプチド |
| GB0127983D0 (en) | 2001-11-22 | 2002-01-16 | Neutec Pharma Plc | Treatment of micro-organism infection |
| JP2008513406A (ja) * | 2004-09-22 | 2008-05-01 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | 免疫原性組成物 |
| GB0515550D0 (en) * | 2005-07-29 | 2005-09-07 | Univ Strathclyde | Inactivation of staphylococcus species |
| WO2008082903A2 (en) * | 2006-12-29 | 2008-07-10 | Dyax Corp. | Methods for making passive immunotherapies |
| US8609364B2 (en) | 2009-05-07 | 2013-12-17 | bioM{tilde over (e)}rieux, Inc. | Methods for antimicrobial resistance determination |
| EP2744517B1 (de) | 2011-08-15 | 2019-03-13 | The University of Chicago | Zusammensetzungen und verfahren in zusammenhang mit antikörpern gegen das staphylokokken-protein a |
| JP2018525848A (ja) | 2015-07-30 | 2018-09-06 | バイタル バイオ、 インコーポレイテッド | 単一ダイオード殺菌 |
| US10918747B2 (en) | 2015-07-30 | 2021-02-16 | Vital Vio, Inc. | Disinfecting lighting device |
| US10357582B1 (en) | 2015-07-30 | 2019-07-23 | Vital Vio, Inc. | Disinfecting lighting device |
| US20180185533A1 (en) | 2016-12-29 | 2018-07-05 | Vital Vio, Inc. | Control systems for disinfecting light systems and methods of regulating operations of disinfecting light systems |
| US10835627B2 (en) | 2017-12-01 | 2020-11-17 | Vital Vio, Inc. | Devices using flexible light emitting layer for creating disinfecting illuminated surface, and related method |
| US10309614B1 (en) | 2017-12-05 | 2019-06-04 | Vital Vivo, Inc. | Light directing element |
| US10413626B1 (en) | 2018-03-29 | 2019-09-17 | Vital Vio, Inc. | Multiple light emitter for inactivating microorganisms |
| US12194168B2 (en) | 2018-12-19 | 2025-01-14 | Vyv, Inc. | Lighting and dissipation device |
| US11639897B2 (en) | 2019-03-29 | 2023-05-02 | Vyv, Inc. | Contamination load sensing device |
| US11541135B2 (en) | 2019-06-28 | 2023-01-03 | Vyv, Inc. | Multiple band visible light disinfection |
| WO2021030748A1 (en) | 2019-08-15 | 2021-02-18 | Vital Vio, Inc. | Devices configured to disinfect interiors |
| WO2021051136A1 (en) | 2019-09-13 | 2021-03-18 | The University Of Chicago | Methods and compositions for treating staphylococcal infections |
| US11878084B2 (en) | 2019-09-20 | 2024-01-23 | Vyv, Inc. | Disinfecting light emitting subcomponent |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6737248B2 (en) * | 1996-01-05 | 2004-05-18 | Human Genome Sciences, Inc. | Staphylococcus aureus polynucleotides and sequences |
| GB9614274D0 (en) * | 1996-07-06 | 1996-09-04 | Univ Manchester | Treatment and diagnosis of infections of gram positive cocci |
| DE69739715D1 (de) * | 1996-11-13 | 2010-02-04 | Du Pont | Herstellungsverfahren von 1,3-propandiol durch rekombinante organismen |
| US6380370B1 (en) * | 1997-08-14 | 2002-04-30 | Genome Therapeutics Corporation | Nucleic acid and amino acid sequences relating to Staphylococcus epidermidis for diagnostics and therapeutics |
| US6300094B1 (en) * | 1997-12-18 | 2001-10-09 | Smithkline Beecham Corporation | Polynucleotides encoding a novel ABC transporter |
-
1998
- 1998-03-31 GB GBGB9806762.2A patent/GB9806762D0/en not_active Ceased
-
1999
- 1999-03-25 EP EP99913444A patent/EP1068328B1/de not_active Expired - Lifetime
- 1999-03-25 WO PCT/GB1999/000939 patent/WO1999050418A1/en not_active Ceased
- 1999-03-25 AT AT99913444T patent/ATE310088T1/de active
- 1999-03-25 DK DK99913444T patent/DK1068328T3/da active
- 1999-03-25 AU AU31566/99A patent/AU752794B2/en not_active Ceased
- 1999-03-25 DE DE69928384T patent/DE69928384T2/de not_active Expired - Lifetime
- 1999-03-25 JP JP2000541306A patent/JP4460156B2/ja not_active Expired - Fee Related
- 1999-03-25 CA CA002321960A patent/CA2321960A1/en not_active Abandoned
- 1999-03-25 ES ES99913444T patent/ES2248992T3/es not_active Expired - Lifetime
- 1999-03-25 NZ NZ506196A patent/NZ506196A/en unknown
-
2000
- 2000-09-29 US US09/672,494 patent/US6627730B1/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999050418A1 (en) | 1999-10-07 |
| ATE310088T1 (de) | 2005-12-15 |
| ES2248992T3 (es) | 2006-03-16 |
| JP2002509724A (ja) | 2002-04-02 |
| US6627730B1 (en) | 2003-09-30 |
| DE69928384D1 (de) | 2005-12-22 |
| NZ506196A (en) | 2002-02-01 |
| AU752794B2 (en) | 2002-10-03 |
| DE69928384T2 (de) | 2006-06-01 |
| AU3156699A (en) | 1999-10-18 |
| GB9806762D0 (en) | 1998-05-27 |
| EP1068328A1 (de) | 2001-01-17 |
| EP1068328B1 (de) | 2005-11-16 |
| JP4460156B2 (ja) | 2010-05-12 |
| CA2321960A1 (en) | 1999-10-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1068328T3 (da) | Behandling og diagnose af stafylokokinfektioner | |
| DK1212422T3 (da) | Humane CTLA-4-antistoffer og anvendelserne deraf | |
| EA200300464A1 (ru) | ГУМАНИЗИРОВАННОЕ АНТИТЕЛО ПРОТИВ РЕЦЕПТОРА ЛИМФОТОКСИНА-β (ВАРИАНТЫ), КОМПОЗИЦИЯ, СПОСОБ ЛЕЧЕНИЯ ИЛИ СНИЖЕНИЯ РИСКА РАЗВИТИЯ, ТЯЖЕСТИ ИЛИ ПОСЛЕДСТВИЙ НЕОПЛАЗИИ У ЧЕЛОВЕКА, ВЫДЕЛЕННАЯ НУКЛЕИНОВАЯ КИСЛОТА (ВАРИАНТЫ), КЛЕТКА КЛЕТОЧНОЙ ЛИНИИ | |
| IS8950A (is) | Einklóna mótefni gegn CTLA-4 úr manni. | |
| NO20041917L (no) | Spesifikke midler som binder humant angiopoietin-2 | |
| DE60131138D1 (de) | Antibakterielle mittel | |
| DK0986577T3 (da) | Opsonisk og beskyttende monoklonale og kimære antistoffer specifikke for lipoteichoicsyre af grampositive bakterier | |
| ATE355293T1 (de) | Substituierte 7-aza-(2.2.1)bicycloheptane für die behandlung von krankheiten | |
| ATE412432T1 (de) | Internalisierende erbb2 antikörper | |
| BR0116686A (pt) | Anticorpos anti-cd28 silenciados e uso dos mesmos | |
| CY1106234T1 (el) | Συνθεσεις για τη θepαπεια μολυνσεων staphylococcus aureus | |
| GB0008305D0 (en) | Treatment of fungal infections | |
| PT827512E (pt) | Anticorpo especifico para staphylococcus aureus e sua utilizacao | |
| ATE319439T1 (de) | Mittel zur behandlung von erkrankungen des tracheo-bronchialtraktes, insbesondere der copd | |
| EP1074173A4 (de) | Ungekehrt freitragende federklammer. | |
| EP1262556A3 (de) | Antimikrobielle Peptide und Verfahren zu ihrer Identifizierung und Verwendung | |
| TR200002114T2 (tr) | N-Aril-Triyazolin(eti)yon ve N-Arilsülfonil-Amino-(Tiyo)karbonil-Triyazolin(eti)yon Tabanlı seçilmiş herbisitler | |
| BR9916507A (pt) | Proteìnas | |
| BR0015872A (pt) | Agentes antitrombóticos | |
| MXPA01010437A (es) | Complejo epitope fab del anticuerpo monoclonal 2f5 de neutralizacion cruzada de hiv-1. | |
| NO20010140L (no) | Kjemotakse-inhiberende protein av Staphylococcus (CHIPS) og dets anvendelse | |
| EP0617889A3 (de) | Herbizide Zusammensetzung. | |
| ATE277924T1 (de) | Aryl-8-azabicyclo(3.2.1)octanes für die behandlung von depression | |
| FR2793385B1 (fr) | Agrafe de palissage autocassante | |
| NO20005548D0 (no) | Mykobakterieinhibitorer |